PAVM PAVMED INC Contract Awards 8-K Filing 2025 - Stock Offering On March 5, 2025, Lucid Diagnostics, a subsidiary of PAVmed Inc., sold 13,939,331 shares at $1.10 each, raising approximately $14.5 million for working capital and corporate purposes.Get access to all SEC 8-K filings of the PAVMED INC